• Novo Nordisk EPS for the quarter ending September 30, 2024 was $0.90, a 23.56% increase year-over-year.
• Novo Nordisk 2023 annual EPS was $2.7, a 56.3% increase from 2022.
• Novo Nordisk 2022 annual EPS was $1.73, a 4.85% increase from 2021.
• Novo Nordisk 2021 annual EPS was $1.65, a 19.57% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.